1. Bhattacharya S, Ammini AC, Jyotsna V, Gupta N, Dwivedi S. Recovery of β-cell functions with low-dose insulin therapy: study in newly diagnosed type 2 diabetes mellitus patients. Diabetes Technol Ther. 2011;13:461-465
  2. Ammini AC, Bhattacharya S, Sahoo JP, Philip J, Tandon N, Goswami R, Jyotsna VJ, Khadgawat R, Chumber S, Seth A, Karak AK, Sharma BS, Chandra PS, Suri A, Sharma MS, Kale SS, Singh M. Cushing’s disease: results of treatment and factors affecting outcome. Hormones (Athens). 2011;10:222-229.
  3. Khandelwal D, Bhattacharya S, Gadodia A, Khadgawat R, Tandon N, Ammini AC. Metabolic bone disease as a presenting manifestation of primary Sjögren’s syndrome: Three cases and review of literature. Indian J Endocrinol Metab. 2011;15:341-345.
  4. Bhattacharya S, Tandon N. Neuroendocrinology. In: Dhawan B.N, Seth P.K editors. Neurosciences in India 2009. Lucknow. Indian Academy of Neurosciences and central Scientific and Industrial Research; 2009. 355-64
  5. Chittawar S, Bhattacharya S, Sahoo J P, et al. Internal jugular vein: Peripheral vein adrenocorticotropic hormone ratio in patients with adrenocorticotropic hormone- dependent Cushing’s syndrome: Ratio calculated from one adrenocorticotropic hormone sample each from right and left internal jugular vein during corticotrophin releasing hormone stimulation test. Indian J Endocrinol Metab. 2013;17:128-32
  6. Khandelwal D, Bhattacharya S, Khadgawat R, Kaur S, Tandon N, Ammini AC. Hypokalemic paralysis as a presenting manifestation of primary Sjögren’s syndrome: A report of two cases. Indian J Endocr Metab 2012;16:853-5
  7. Surana V, Aggarwal S, Khandelwal D, Singla R, Bhattacharya S, Chittawar S, Kalra S, Dutta D; Society for Promotion of Education in Endocrinology and Diabetes Group, India. A 2016 clinical practice pattern in the management of primary hypothyroidism among doctors from different clinical specialties in New Delhi. Indian J Endocrinol Metab. 2017 Jan-Feb;21(1):165-177
  8. Bhattacharya S, Sachdeva M; An unusual cause of hypoglycemia in a child with Acute Lymphoblastic Leukemia. Endocrine Practice. 2017: 23 (Suppl): 88
  9. Bhattacharya S, Khadgawat R, Ammini A C, Grewal E, Gupta A, Seth A, Gadodia A. Cherubism or craniofacial fibrous dysplasia? A diagnostic dilemma! Horm Res 2008;70(suppl 3):28
  10. Surana V, Singla R, Aggarwal S, Khandelwal D, Bhattacharya S, Kalra S, Dutta D. Short Stature – Clinical Approach to Diagnosis: A 2018 Perspective. J Indian Med Assoc. 2018; 116: 56-62
  11. Dutta P, Gupta G, Singla R, Kantroo V, Bandyopadhyay D, Dutta D, Bhattacharya S. Artificial Sweeteners: Clinical Perspective. J Indian Med Assoc. 2018; 116: 67-71
  12. Rosha R, Bhattacharya S, Aggarwal S, Singla R. Type 2 Diabetes Reversal in India: Is a Low Carbohydrate Diet Practical and Sustaianable. J Indian Med Assoc. 2018; 116: 85-88
  13. Bhattacharya S, Adhikary AK, Mondal S, Bandyopadhyay D. SGLT2 Inhibitors and Cardiovascular Outcomes: Inferences for Clinical Practice. J Indian Med Assoc. 2018;116: 89-92
  14. Dutta D, Khandelwal D, Chittawar S, Aggarwa S, Bhattacharya S, Surana V, Singla R, Kalra S. Bone Health Clinical Practice in India— Concern Regarding Vitamin D Toxicity. US Endocrinology. 2018;14(2):87–92
  15. 15. Bhattacharya S. Hypothyroidism during pregnancy. In: Aggarwal S, Kalra S editors. Pregnancy and thyroid disorders. Evangel 2018.
  16. Dutta D, Shrestha D, Khandelwal D, Baruah M, Kalra S, Agarwal S, Bhattacharya S, Singla R, Surana V. A 2018 clinical practice pattern in the management of diabetes in India and Nepal: a three-city study. Int J Diabetes Dev Ctries. 2019; 39:557–567. doi: 10.1007/s13410-018-0701-7
  17. Bhattacharya S, Malhotra R. Combination of SGLT 2 inhibitors and DPP4 inhibitors. In: Aggarwal S, Kalra S editors. SGLT 2 Inhibitors: Clinical manual. Evangel 2019.
  18. Kalra S, Das AK, Sahay RK, Baruah MP, Tiwaskar M, Das S, Chatterjee S, Saboo B, Bantwal G, Bhattacharya S, et al. Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force. Diabetes Ther. 2019 Jul 29. doi: 10.1007/s13300-019-0669-4.
  19. Arora B, Gupta L, Khandelwal D, Bhattacharya S, Kalra S, Chittawar S, et al. Knowledge, attitude, and practices of fasts in patients with type 2 diabetes among different religions in North India. Int J Diabetes Dev Ctries. 2019; doi: 10.1007/s13410-019-00760-z
  20. Bhattacharya S, Sehgal A, Kalra S. All Thyrotoxicosis is not Graves’ Disease. J Indian Med Assoc. 2019; 117: 18-20
  21. Bhattacharya S, Kalra S, Dutta D, Khandelwal D, Singla R. The Interplay Between Pituitary Health and Diabetes Mellitus – The Need for ‘Hypophyseo-Vigilance’. Eur Endocrinol. 2020;16(1):25-31. doi:10.17925/EE.2020.16.1.25
  22. Dutta D, Sharma M, Aggarwal S, Mohindra R, Bhattacharya S, Kalra S. Vitamin D, thyroid autoimmunity and cancer: An interplay of different factors. Indian J Endocr Metab 2019;23:507-13
  23. Arora B, Gupta L, Khandelwal D, Bhattacharya S, Kalra S, Chittawar S, et al. Knowledge, attitude, and practices of fasts in patients with type 2 diabetes among different religions in North India. Int. J. Diabetes Dev. Ctries. 2019; 10.1007/s13410-019- 00760-z.
  24. Goyal A, Bhattacharya S, Shahjada S. Endocrine Syndromes in Diabetes. In: Kalra S, Priya G. Glucocrinology: The Relationship between Glucose and Endocrine Function. Jaypee Brothers, 2019.
  25. Krishnamurthy A, Bhattacharya S. Classification of Insulin Regimens. In: Aggarwal S, Kalra S editors. Insulin Manual. Evangel 2020.
  26. Kantroo V, Bhattacharya S. Insulin in Critical Care. In: Aggarwal S, Kalra S editors. Insulin Manual. Evangel 2020.
  27. Kalra S, Bhattacharya S, Joshi A. Osteocrinology. Osteoporos Int. 2020.
  28. Bhattacharya S, Goyal A, Kaur P, Singh R, Kalra S. Anticancer Drug-induced Thyroid Dysfunction. Eur Endocrinol. 2020;16(1):32-39. doi:10.17925/EE.2020.16.1.32
  29. Gupta L, Arora B, Khandelwal D, Lal PR, Kalra S, Bhattacharya S, et al. Dietary practices during common religious fasts in people with type 2 diabetes mellitus among different religions in north India – A questionnaire based study. US Endocrinology. 2020;16(1): Epub ahead of publication
  30. Kalra S, Priya G, Bhattacharya S, Sahay R. Oncocrinology. J Pak Med Assoc. 2020 Apr;70(4):757-761.
  31. Kalra S, Iraqi H, Sahay R, Bhattacharya S. The glycaemic personality: A SURE framework of person-centred choice in diabetes care. J Pak Med Assoc. 2020 Apr;70(7):1285-1286.
  32. Bhattacharya S, Krishnamurthy A, Gopalakrishnan M, Kalra S, Kantroo V, Aggarwal S, Surana V. Endocrine and Metabolic Manifestations of Snakebite Envenoming. Am J Trop Med Hyg. 2020 Oct;103(4):1388-1396. doi: 10.4269/ajtmh.20-0161. PMID:32602439; PMCID: PMC7543852.
  33. Lakhani O, Shaikh A, Krishnamurthy A, Bhograj, Patil, Shenoy, Bhattacharya S, Somani, Lathia T (2020). FREQUENTLY ASKED QUESTIONS ON USING TELEMEDICINE BY ENDOCRINOLOGISTS IN INDIA. 10.13140/RG.2.2.12274.04808.
  34. Lakhani OJ, Lathia T, Bhattacharya S, Shaikh A. “Telethyroidology”: Managing thyroid disorders through telemedicine. Thyroid Res Pract. 2020;17:56-61
  35. Bhattacharya S, Kalra S. Quinary Prevention and Bariatric surgery. J Pak Med Assoc. 2020 Sep;70(9):1664-1666. PMID: 33040136.
  36. Krishnamurthy A, Bhattacharya S, Lathia T, Kantroo V, Kalra S, Dutta D. Anticancer Medications and Sodium Dysmetabolism. Eur Endocrinol. 2020 Oct;16(2):122-130. doi: 10.17925/EE.2020.16.2.122. Epub 2020 Oct 6. PMID: 33117443; PMCID: PMC7572166.
  37. Kalra S, Bhattacharya S, Kalhan A. Testosterone in COVID-19 – Foe, Friend or Fatal Victim? Eur Endocrinol. 2020 Oct;16(2):88-91. doi: 10.17925/EE.2020.16.2.88. Epub 2020 Oct 6. PMID: 33117437; PMCID: PMC7572157.
  38. Dutta D, Bhattacharya S, Surana V, Aggarwal S, Singla R, Khandelwal D, Sharma M. Efficacy and safety of saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta-analysis. Diabetes Metab Syndr. 2020 Sep 6;14(6):1759-1768. doi: 10.1016/j.dsx.2020.08.039. Epub ahead of print. PMID: 32937280.
  39. Dutta D, Bhattacharya S, Surana V, Aggarwal S, Singla R, Khandelwal D, Sharma M. Response to the letter to the editor submitted by Jaiswal A et al. (2020) regarding ‘efficacy and safety of saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta- analysis’ (Dutta et al.). 2020 Oct 29;14(6):2093. doi: 10.1016/j.dsx.2020.10.027.
  40. Dutta D, Bhattacharya S, Krishnamurthy A, Sharma LK, Sharma M. Efficacy and safety of novel dipeptidyl-peptidase-4 inhibitor evogliptin in the management of type 2 diabetes mellitus: A meta-analysis. Indian J Endocr Metab 2020;24:434-45.
  41. Kalra S, Singla R, Dhawan M, Bhattacharya S, Aggarwal S. The Islet De-stress Hypothesis: A potential explanation for the gluco-metabolic effects of ketogenic diet. J Pak Med Assoc. 2020;70(12):2285-2288.
  42. Kalra B, Kalra S, Bhattacharya S, Dhingra A. Menopause distress: A person centered definition. J Pak Med Assoc. 2020;70(12-B):2481-2482.
  43. Kalra S, Kapoor N, Bhattacharya S, Aydin H, Coetzee A. Barocrinology: The Endocrinology of Obesity from Bench to Bedside. Med. Sci. 2020, 8, 51.
  44. Dutta D, Bhattacharya S, Sharma M. et al. Effect of yoga on glycemia and lipid parameters in type-2 diabetes: a meta-analysis. J Diabetes Metab Disord. 2021. DOI: 10.1007/s40200-021-00751-0
  45. Kantroo V, Bhattacharya S, Dhingra A, Kalra S. Pulmocrinology: Interplay of pulmonary and endocrine diseases. J Pak Med Assoc. 2021;71(3):1033-1038.
  46. Kalra S, Dhingra A, Sharma SK, Bhattacharya S. Sheehan’s syndrome as a mimic of premature ovarian insufficiency: need for advocacy, Climacteric, 2021. DOI: 10.1080/13697137.2021.1905626
  47. Kapoor N, Sahay R, Kalra S, Bajaj S, Dasgupta A, Shrestha D, Dhakal G, Tiwaskar M, Sahay M, Somasundaram N, Reddy R, Bhattacharya S, Reddy VB, Viswanathan V, Krishnan D, Baruah M, Das AK. Consensus on Medical Nutrition Therapy for Diabesity (CoMeND) in Adults: A South Asian Perspective. Diabetes Metab Syndr Obes. 2021;14:1703-1728. DOI: 10.2147/DMSO.S278928
  48. Kalra S, Bhattacharya S, Mittal R. The diabetic muscle. J Pak Med Assoc. 2021;71(5):1503-1505
  49. Kalra S, Bhattacharya S. Metabolic optimization in diabetes: A hierarchial model. J Pak Med Assoc. 2021;71(5):1506-1507
  50. Kalra S, Bhattacharya S, Rawal P. Hepatocrinology. Med Sci (Basel). 2021 Jun 1;9(2):39. doi: 10.3390/medsci9020039.
  51. Kalra S, Bhattacharya S, Kapoor N. Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs). Diabetes Ther. 2021 Jul 15. doi: 10.1007/s13300- 021-01113-y. Epub ahead of print. PMID: 34268675.
  52. Bhattacharya S, Kubihal S, Tyagi P. Fungi and Endocrine Dysfunction. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext. South Dartmouth (MA):, Inc.; June 25, 2021.
  53. Bhattacharya S, Nagendra L, Krishnamurthy A, Lakhani OJ, Kapoor N, Kalra B, Kalra S. Early Gestational Diabetes Mellitus: Diagnostic Strategies and Clinical Implications. Med Sci (Basel). 2021 Sep 23;9(4):59. doi: 10.3390/medsci9040059.
  54. Bhattacharya S, Kalra S, Kapoor N, Singla R, Dutta D, Aggarwal S, Khandelwal D, Surana V, Dhingra A, Kantroo V, Chittawar S, Deka N, Bindal V, Dutta P. Expert opinion on the preoperative medical optimization of adults with diabetes undergoing metabolic surgery. World J Diabetes 2021; 12(10): 1587-1621 [DOI: 10.4239/wjd.v12.i10.1587]
  55. Kalra S, Bantwal G, Kapoor N, Sahay R, Bhattacharya S, Anne B, Gopal RA, Kota S, Kumar A, Joshi A, Sanyal D, Tiwaskar M, Das AK. Quantifying Remission Probability in Type 2 Diabetes Mellitus. Clin Pract. 2021. 9;11(4):850-859. doi: 10.3390/clinpract11040100.
  56. Kalra S, Das S, Kota S, Anne B, Kumar A, Punyani H, Joshi A, Unnikrishnan AG, Bhattacharya S, Kapoor N. Barophenotypic Characterization – The key to Person Centric Management of Obesity. Indian J Endocrinol Metab. 2021;25(4):295-298. doi: 10.4103/ijem.ijem_285_21.
  57. Kalra S, Bhattacharya S, Sahay R. Prediabetes: A pragmatic triage for preventive pharmacotherapy. J Pak Med Assoc. 2021;72(2):369-372. doi: 10.47391/JPMA.22-36
  58. Kalra S, Bhattacharya S, Sahay R. Pragmatic Parsimony in COVID-19 management. J Assoc Physicians India. 2022 Jan;70(2):83
  59. Kalra S, Bhattacharya S, Kapoor N. Glucagon-Like Peptide 1 Receptor Agonists (GLP1RA) and Sodium-glucose co-transporter-2 inhibitors (SGLT2i): Making a pragmatic choice in diabetes management. J Pak Med Assoc. 2022;72(5):989-990 doi: 10.47391/JPMA.22-64
  60. Shah P, Kalra S, Yadav Y, Deka N, Lathia T, Jacob JJ, Kota SK, Bhattacharya S, Gadve SS, et al. Management of Glucocorticoid-Induced Hyperglycemia. Diabetes Metab Syndr Obes. 2022;15:1577-1588. doi: 10.2147/DMSO.S330253.
  61. Kalra S, Dhar M, Afsana F, Aggarwal P, Aye TT, Bantwal G, Barua M, Bhattacharya S, Das A K, Das S et al.. 2022. Asian Best Practices for Care of Diabetes in Elderly (ABCDE). Rev Diabet Stud. 18(2):100-134.
  62. Kalra S, Bantwal G, Sahay RK, Bhattacharya S, Baruah MP, Sheikh S, Lathia T. Incorporating Integrated Personalised Diabetes Management (iPDM) in Treatment Strategy: A Pragmatic Approach. Indian J Endocrinol Metab. Vol 26: Issue 2: Page 106-110, March-April 2022.
  63. Dutta D, Surana V, Bhattacharya S, Aggarwal S, Sharma M. Efficacy and Safety of Novel Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in the Management of Diabetic Kidney Disease: A Meta-analysis. Indian J Endocrinol Metab. Vol 26: Issue 3: Page 198-205, May-June 2022
  64. Kapoor N, Bhattacharya S, Agarwal N, Das S, Bantwal G, Deshmukh V, Kalra S. Subclinical Kwashiorkor in Adults: A New Age Paradigm. Indian J Endocrinol Metab. Vol 26: Issue 3: Page 213-222, May-June 2022 
  65. Bhattacharya S, Kantroo V, Atreja A, Kalra S. The Somno-Metabolic syndrome: Screening for obstructive sleep apnoea in metabolic syndrome. . J Pak Med Assoc. Vol 72: Issue 10: Page 2117-2118, October 2022
  66. Bhattacharya S, Anne B, Tyagi P, Nagendra L, Kalra S. Diabetes and severe COVID-19 infection: Connecting the dots. J Pak Med Assoc. Vol 72: Issue 11: Page 2332-2334, November 2022
  67. Dutta D, Bhattacharya S, Kumar M, Datta PK, Mohindra R, Sharma M. Efficacy and safety of novel thiazolidinedione lobeglitazone for managing type-2 diabetes a meta-analysis. Diabetes Metab Syndr. Vol 17: Issue 1:102697, December 2022
  68. Kalra S, Agrawal N, Bhattacharya S, Sahay R. The somnometabolic syndrome. Bangladesh J Endocrinol Metab. Vol 1: Issue 1: Pages 5-6, June 2022
  69. Kalra S, Kumar S, Bhattacharya S. Glycemic Guardianship: World Health Organization Leads the Way. Indian J Clin Pract. Vol. 33: Issue 4: Pages 7-9. September 2022. 
  70. Kalra S, Bhattacharya S, Shaikh S. Imeglimin: Finding a Place in Modern Diabetes Pharmacotherapeutics. Indian J Clin Pract. Vol. 33: Issue 5: Pages 8-10. October 2022
  71. Saptarshi Bhattacharya, Disorders of anterior pituitary, Section 6, Chapter 4, API Textbook of Medicine, Editor – Sandhya A Kamath, 12th edition, Jaypee Brothers Medical Publishers, 564-576, 2022
  72. Gangopadhyay KK, Sahay RK, Gupta S, Ayyar V, Das S, Bhattacharya S, Bhandari S, Bhattacharyya A. Discharge Planning for People with Inpatient Hyperglycaemia: A Review on Pharmacological Management. Curr Diabetes Rev. 2023;19(9):e240223214030. doi: 10.2174/1573399819666230224123707. PMID: 36825710.
  73. Kantroo V, Atreja A, Bhattacharya S, Shaikh S, Kalra S. The diabetic lung. J Pak Med Assoc. 2023 Jan;73(1):191-192. doi: 10.47391/JPMA.03-23. PMID: 36842039.
  74. Kalra S, Kalra B, Bhattacharya S. Insulin hesitancy: A language-based model. J Pak Med Assoc. 2023 Jan;73(1):193-194. doi: 10.47391/JPMA.04-23. PMID: 36842040.
  75. . Chopra A, Xavier D, George B, Bantwal G, Sahay R, Kumar KH, Madhu SV, Bhattacharya S. Strategies for Promoting Research among Endocrinologists in Private Practice. Indian J Endocrinol Metab. 2023 Jan-Feb;27(1):28-31. doi: 10.4103/2230-8210.370909. Epub 2023 Mar 3. PMID: 37215263; PMCID: PMC10198198.
  76. *5. Nagendra L, Bhattacharya S, Kalra S, Kapoor N. Metformin in COVID-19: Is There a Role Beyond Glycemic Control? Int J Endocrinol Metab. 2023 Apr 20;21(2):e132965. doi: 10.5812/ijem-132965. PMID: 37654526; PMCID: PMC10467582.
  77. *6. Bhattacharya S, Kalra S. The AACE 2022 Guideline: An Academic Appraisal. touchREV Endocrinol. 2023 May;19(1):2-3. doi: 10.17925/EE.2023.19.1.2. Epub 2023 Mar 31. PMID: 37313237; PMCID: PMC10258625.
  78. *7. Dutta D, Nagendra L, Raizada N, Bhattacharya S, Sharma M. Verapamil improves One-Year C-Peptide Levels in Recent Onset Type-1 Diabetes: A Meta-Analysis. Indian J Endocrinol Metab. 2023 May-Jun;27(3):192-200. doi: 10.4103/ijem.ijem_122_23. Epub 2023 Jun 26. PMID: 37583402; PMCID: PMC10424102.
  79. *8. Kalra S, Bhattacharya S, Dhingra A. NANOCRINOLOGY. J Pak Med Assoc. 2023 Jun;73(6):1334-1335. doi: 10.47391/JPMA.23-41. PMID: 37427646.
  80. *9. Nagendra L, Kapoor N, Bhattacharya S. Metabolic Bone Disease in the Tropics. 2023 Jun 13. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA):, Inc.; 2000–. PMID: 37368986.
  81. *10. Gujjar P, Ravikumar YS, Nagendra L, Boro H, Bhattacharya S. Cardiac Autonomic Neuropathy in Prediabetes: A Case-Control Study. Indian J Endocrinol Metab. 2023 Jul-Aug;27(4):325-329. doi: 10.4103/ijem.ijem_50_23. Epub 2023 Aug 28. PMID: 37867983; PMCID: PMC10586559.
  82. *11. Dutta D, Kadian J, Maisnam I, Kumar A, Bhattacharya S, Sharma M. Efficacy and Safety of Novel Thiazolidinedione Rivoglitazone in Type-2 Diabetes a Meta-Analysis. Indian J Endocrinol Metab. 2023 Jul-Aug;27(4):286-295. doi: 10.4103/ijem.ijem_17_23. Epub 2023 Aug 28. PMID: 37867986; PMCID: PMC10586552.
  83. *12. Bhattacharya S, Nagendra L, Chandran M, Kapoor N, Patil P, Dutta D, Kalra S. Trabecular bone score in adults with type 1 diabetes: a meta-analysis. Osteoporos Int. 2023 Oct 11. doi: 10.1007/s00198-023-06935-z. Epub ahead of print. PMID: 37819402.
  84. *13. Bhattacharya S, Kalra S. ADA–EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes in an Afro-Asian Context: Broadening the Perspective. touchREV Endocrinol. 2023;19(2):Epub ahead of journal publication.
  85. *14. Thakkar S, Chopra A, Nagendra L, Kalra S, Bhattacharya S. Teplizumab in Type 1 Diabetes Mellitus: An Updated Review. touchREV Endocrinol. 1 9(2):1–8:Online ahead of journal publication.
  86. *15. Bhattacharya S, Kalra S. South Asian Endocrinology: Challenges and Concerns, Collaboration and Consolidation. Indian Journal of Endocrinology and Metabolism 27(5):p 373-376, Sep–Oct 2023. | DOI: 10.4103/ijem.ijem_334_23
  87. *16. Nagendra L, Mondal S, Bhat S, Boro H, George B, Bhattacharya S, Kalra S. PURsuit of Endocrinology (PURE): A National Survey among First-Year Endocrinology Residents Across India. Indian Journal of Endocrinology and Metabolism 27(5):p 450-455, Sep–Oct 2023. | DOI: 10.4103/ijem.ijem_2_23
Scroll to Top